Zepp Health Corp
NYSE:ZEPP
Zepp Health Corp
Cash & Cash Equivalents
Zepp Health Corp
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zepp Health Corp
NYSE:ZEPP
|
Cash & Cash Equivalents
¥928.2m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
C
|
China Railway Signal & Communication Corp Ltd
SSE:688009
|
Cash & Cash Equivalents
¥22B
|
CAGR 3-Years
1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
Universal Scientific Industrial Shanghai Co Ltd
SSE:601231
|
Cash & Cash Equivalents
¥11.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
17%
|
CAGR 10-Years
16%
|
|
Hangzhou Hikvision Digital Technology Co Ltd
SZSE:002415
|
Cash & Cash Equivalents
¥49.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
29%
|
|
Zhejiang Dahua Technology Co Ltd
SZSE:002236
|
Cash & Cash Equivalents
¥11.8B
|
CAGR 3-Years
33%
|
CAGR 5-Years
43%
|
CAGR 10-Years
23%
|
|
Zhejiang Supcon Technology Co Ltd
SSE:688777
|
Cash & Cash Equivalents
¥5.4B
|
CAGR 3-Years
60%
|
CAGR 5-Years
91%
|
CAGR 10-Years
N/A
|
See Also
What is Zepp Health Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
928.2m
CNY
Based on the financial report for Sep 30, 2023, Zepp Health Corp's Cash & Cash Equivalents amounts to 928.2m CNY.
What is Zepp Health Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-6%
Over the last year, the Cash & Cash Equivalents growth was -2%. The average annual Cash & Cash Equivalents growth rates for Zepp Health Corp have been -30% over the past three years , -6% over the past five years .